Interesting T2DM: ED, Early Menopause and Diabetes Risk

July 25, 2017
Julie Bowen

A top-line look at the latest news: novel risk factors, insulin vs insulin; and predictors of weight loss success.

Click through the slides above for our monthly at-a-glance reviews of recent studies in type 2 diabetes mellitus. Among our late July topics:
• Novel risk factors for T2DM and its complications
• A head-to-head comparison of insulins
• Biomarkers that predict weight loss successSee the slide legends for links to the article summaries.

High Prevalence of Erectile Dysfunction in Diabetes: a Systematic Review and Meta-analysis of 145 Studies. Abstract link.

Obstructive Sleep Apnoea and Retinopathy in Patients With Type 2 Diabetes: A Longitudinal Study. Abstract link.

Age at Natural Menopause and Risk of Type 2 Diabetes: A Prospective Cohort Study.

Abstract link.

Associations of Weight Gain From Early to Middle Adulthood With Major Health Outcomes Later in Life.

Abstract link.

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.

Abstract link.

Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients With Type 2 Diabetes.

Abstract link.

Pretreatment Fasting Plasma Glucose and Insulin Modify Dietary Weight Loss Success: Results From 3 Randomized Clinical Trials.

Abstract link.

PreviousNext

Related Content:

Diabetes
Dapagliflozin Effective for Reducing CV Risk in Diabetes, Irrespective of Kidney Function
Race, Gender, & Income Influence Access to SGLT2 Inhibitors Among US Patients
Low-Intensity Walking Program Fails to Show Benefit for Peripheral Artery Disease